Induction of apoptosis by evodiamine involves both activation of mitotic arrest and mitotic slippage

Li-Hong Zhu1, Wei Bi, Xiao-Dong Liu

  • 1Department of Pathophysiology, Medical College of Jinan University, and Department of Neurology, First Affiliated Hospital of Jinan University, Guangzhou 510632, PR China.

Oncology Reports
|September 3, 2011
PubMed

Insights

Evodiamine (Evo) inhibits gastric cancer cell growth by causing mitotic arrest and slippage. Sustained arrest is crucial for Evo to induce apoptosis, offering potential cancer treatment strategies.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cancer Research

Background:

  • Evodiamine (Evo), an alkaloid from Evodia rutaecarpa, shows anti-proliferative and anti-tumor effects.
  • The precise mechanisms and molecular targets of Evo's anti-cancer activity remain largely unelucidated.
  • Understanding Evo's action is critical for its potential therapeutic applications in oncology.

Purpose of the Study:

  • To investigate the anti-proliferative and apoptotic mechanisms of Evodiamine (Evo) in human gastric cancer cells (SGC-7901).
  • To establish a cell synchronization model for detailed mechanistic studies of Evo.
  • To elucidate the role of mitotic arrest and mitotic slippage in Evo-induced apoptosis.

Main Methods:

  • Utilized a cell synchronization model in SGC-7901 human gastric cancer cells.
  • Transfected cells with full-length or non-degradable (ND) cyclinB1 to assess Evo's effects.
  • Investigated the impact of transient vs. sustained Evo treatment and CDK1 inhibition on apoptosis and mitotic events.

Main Results:

  • Evodiamine (Evo) significantly inhibited SGC-7901 cell proliferation and exhibited cytotoxicity.
  • Transient Evo treatment induced reversible mitotic arrest; sustained arrest (>16-20 hours) was necessary for apoptosis induction.
  • Promoting mitotic slippage enhanced apoptosis, while delaying it via ND cyclinB1 overexpression reduced Evo's apoptotic effects.

Conclusions:

  • Evodiamine (Evo)-induced apoptosis in gastric cancer cells is intrinsically linked to mitotic arrest and subsequent mitotic slippage.
  • The findings suggest that Evo's anti-cancer properties may stem from its ability to disrupt mitotic progression and induce cell death.
  • This study provides mechanistic insights into Evodiamine's potential as a therapeutic agent for cancer treatment and prevention.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...